170 related articles for article (PubMed ID: 10442360)
21. Capecitabine and tegafur + uracil: new preparations. Metastatic colorectal cancer: two oral fluorouracil precursors, few advantages.
Prescrire Int; 2002 Apr; 11(58):44-7. PubMed ID: 11987311
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancer.
Klaassen U; Borquez D; Lang S; Oberhoff C; Harstrick A; Seeber S; Benner S
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):71-3. PubMed ID: 10442367
[TBL] [Abstract][Full Text] [Related]
23. UFT in the treatment of colorectal and breast cancer.
Sun W; Haller D
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):49-56. PubMed ID: 11219978
[TBL] [Abstract][Full Text] [Related]
24. A retrospective comparison of concurrent 5-fluorouracil or oral UFT in postoperative chemoradiation for gastric adenocarcinoma.
Yoney A; Bati Y; Akboru H; Isikli L; Unsal M
Cancer Radiother; 2010 Jan; 14(1):19-23. PubMed ID: 19963423
[TBL] [Abstract][Full Text] [Related]
25. Uracil/tegafur plus oral calcium folinate in advanced breast cancer.
Richardet E; Pedraza C; Mickiewicz E; Lerzo G; Bonamasa M; Coppola F; Elli A; Uranga G; Jovtis S; Bruno M; Ventriglia M; Cuevas MA; Alvarez AM; Suarez LA; Fein L
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):96-7. PubMed ID: 10442373
[TBL] [Abstract][Full Text] [Related]
26. A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada.
Maroun J; Asche C; Romeyer F; Mukherjee J; Cripps C; Oza A; Skillings J; Letarte J
Pharmacoeconomics; 2003; 21(14):1039-51. PubMed ID: 13129416
[TBL] [Abstract][Full Text] [Related]
27. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
28. Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06.
Kopec JA; Yothers G; Ganz PA; Land SR; Cecchini RS; Wieand HS; Lembersky BC; Wolmark N
J Clin Oncol; 2007 Feb; 25(4):424-30. PubMed ID: 17264338
[TBL] [Abstract][Full Text] [Related]
29. Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
Kroep JR; van Werkhoven E; Polee M; van Groeningen CJ; Beeker A; Erdkamp F; Weijl N; van Bochove A; Erjavec Z; Kapiteijn E; Stiggelbout AM; Nortier HW; Gelderblom H
J Geriatr Oncol; 2015 Jul; 6(4):307-15. PubMed ID: 26073532
[TBL] [Abstract][Full Text] [Related]
30. UFT plus calcium folinate/irinotecan in colorectal cancer.
Twelves C
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):51-4. PubMed ID: 10442362
[TBL] [Abstract][Full Text] [Related]
31. Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ; Sonnichsen DS; Birkhofer MJ; Ferreira I; Noel D
Cancer Chemother Pharmacol; 1999; 43(3):221-6. PubMed ID: 9923552
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel, UFT, and calcium folinate in metastatic breast cancer.
Dickson NR; Nicholson BP; Hande K; Blanke C; Johnson D; Cohen A
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):69-70. PubMed ID: 10442366
[TBL] [Abstract][Full Text] [Related]
33. Gemcitabine and UFT plus oral calcium folinate: phase I study.
Philip PA; Ibrahim D; Zalupski M; Arlauskas P; Shields A
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):116-9. PubMed ID: 10442378
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
[TBL] [Abstract][Full Text] [Related]
35. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
[TBL] [Abstract][Full Text] [Related]
36. [A retrospective study of UFT and oral leucovorin plus PSK combination adjuvant chemotherapy in patients with stage III colon cancer].
Tomizawa K; Kumamoto T; Hanaoka Y; Toda S; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Udagawa H; Watanabe G; Sawada T
Gan To Kagaku Ryoho; 2012 Apr; 39(4):571-5. PubMed ID: 22504680
[TBL] [Abstract][Full Text] [Related]
37. UFT plus leucovorin vs 5-FU plus leucovorin for metastatic colorectal cancer.
Carmichael J
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):50-2. PubMed ID: 9348569
[TBL] [Abstract][Full Text] [Related]
38. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
[TBL] [Abstract][Full Text] [Related]
39. Oral uracil-tegafur plus leucovorin vs fluorouracil bolus plus leucovorin for advanced colorectal cancer: a meta-analysis of five randomized controlled trials.
Bin Q; Li J; Liao C; Cao Y; Gao F
Colorectal Dis; 2011 Aug; 13(8):837-45. PubMed ID: 20050863
[TBL] [Abstract][Full Text] [Related]
40. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]